Respiratory Diagnostics Market to Hit USD 9.02 Billion by 2030 with 6.5% CAGR | MarketsandMarkets
The global respiratory diagnostics market, valued at US$ 5.85 billion in 2023, is forecasted to grow at a robust CAGR of 6.5%, reaching US$ ...
Hosted on MSN12d
No, we’re not ‘one mutation away’ from an H5N1 bird flu pandemic – here are the facts
In early December 2024, a group of researchers published an article in the journal Science, entitled “A single mutation in ...
Why QuidelOrtho Stock Bounced More Than 4% Higher Today
Healthcare in vitro diagnostics company QuidelOrtho (NASDAQ: QDEL) attracted the right kind of attention from investors after ...
Aethlon Medical’s Hemopurifier Shows Promise in Oncology Trials
Analyst Vernon Bernardino of H.C. Wainwright reiterated a Buy rating on Aethlon Medical (AEMD – Research Report), retaining the price target of ...
Virpax Confirms Positive Results with US Army with Probudur™ for Combat Care Study
Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) ("Virpax" or the "Company"), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central ...
pharmaphorum3d
Vir awarded $1 billion multi-year BARDA influenza contract
VIR-2482 is an investigational intramuscularly administered influenza A-neutralising mAb. It has been shown in vitro to cover all major influenza A strains that have arisen since the 1918 ...
manilatimes23d
Roche receives FDA clearance with CLIA waiver for cobas® liat molecular tests to diagnose sexually transmitted infections at the point of care
More than 1 million curable sexually transmitted infections (STIs) are acquired every day worldwide in people 15-49 years old, most of which are asymptomatic.1 FDA CLIA-waived tests broaden access to ...
The Taipei Times5d
New cancer signaling mechanism found
Researchers from National Chung Cheng University (CCU) and National Cheng Kung University (NCKU) have identified a novel signaling mechanism in pancreatic cancer patients, knowledge of which might ...